Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
646 |
|
| Actual shortage: | 68 (11%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 16 (2%) | |
| Resolved: | 561 (87%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
17 (22%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OLMESARTAN/HCTZ | 40MG 12.5MG | TABLET | Actual shortage | 2024-03-26 | 2024-12-02 | 223383 |
| OLMESARTAN/HCTZ | 20MG 12.5MG | TABLET | Actual shortage | 2024-03-26 | 2024-11-16 | 223386 |
| OLOPATADINE 0.2% | 0.2% | SOLUTION | Actual shortage | 2025-09-03 | 2025-12-03 | 266471 |
| OLOPATADINE 0.2% | 0.2% | SOLUTION | Resolved | 2025-10-06 | 2025-11-08 | 268678 |
| OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-03-26 | 2024-11-19 | 223352 |
| ONDANSETRON | 4MG | TABLET | Resolved | 2017-03-17 | 2017-10-10 | 3230 |
| ONDANSETRON | 8MG | TABLET | Resolved | 2017-03-17 | 2017-10-10 | 3239 |
| ONDANSETRON | 4MG | TABLET | Resolved | 2017-06-05 | 2017-10-10 | 11803 |
| ONDANSETRON | 8MG | TABLET | Resolved | 2017-06-05 | 2017-10-10 | 11806 |
| ONDANSETRON | 4MG | TABLET | Resolved | 2017-09-13 | 2017-10-05 | 21979 |
| ONDANSETRON | 8MG | TABLET | Resolved | 2017-09-13 | 2017-10-05 | 21982 |
| ONDANSETRON ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-10-21 | 2025-07-10 | 240734 |
| ONDANSETRON ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-11-18 | 2025-09-04 | 243274 |
| ONDANSETRON ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2025-10-06 | 2025-12-04 | 268687 |
| ONDANSETRON ODT | 8MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2025-10-06 | 2025-12-04 | 268690 |
| OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-11-28 | 2019-02-06 | 30915 |
| OXYBUTYNIN | 5MG | TABLET | Resolved | 2017-12-18 | 2019-02-06 | 33667 |
| OXYBUTYNIN | 5MG | TABLET | Resolved | 2024-05-28 | 2025-08-12 | 228963 |
| OXYBUTYNIN | 5MG | TABLET | Resolved | 2024-07-03 | 2025-08-11 | 231993 |
| OXYCODONE/ACET | 325MG 5MG | TABLET | Resolved | 2018-03-13 | 2018-05-03 | 42756 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACEBUTOLOL | Discontinued | 2019-01-22 | 2019-01-22 | 73224 | ||
| ACEBUTOLOL | Discontinued | 2019-01-22 | 2019-01-22 | 73228 | ||
| ACEBUTOLOL | Discontinued | 2019-01-22 | 2019-01-22 | 73233 | ||
| ACYCLOVIR | 400MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4942 |
| ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144035 |
| ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-12-17 | 144038 |
| ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-08-12 | 144041 |
| AMOXICILLIN | 125MG | GRANULES FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4933 |
| AMOXICILLIN | 125MG | GRANULES FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4939 |
| AZATHIOPRINE | 50MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4899 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
| CILAZAPRIL | 2.5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4918 |
| CILAZAPRIL | 1MG | TABLET | Discontinued | 2017-08-02 | 2017-08-02 | 17969 |
| CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4924 |
| CLINDAMYCIN | 150MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4950 |
| CLINDAMYCIN | 300MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4956 |
| CLINDAMYCIN | Discontinued | 2020-02-27 | 2020-02-27 | 107379 | ||
| CLINDAMYCIN | Discontinued | 2020-02-27 | 2020-02-27 | 107383 | ||
| DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |